David D. O'Toole - Jan 3, 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
CFO
Signature
/s/ Donna Shiroma
Stock symbol
RCEL
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 05:49 PM
Previous filing
Dec 12, 2023
Next filing
Feb 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +125K $0.00 125K Jan 3, 2024 Common Stock 125K $12.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Stock Options vest in three equal annual installments beginning with the first anniversary of the grant date.